Related Experiment Video
Updated: Aug 25, 2026

Colon Ascendens Stent Peritonitis (CASP) - a Standardized Model for Polymicrobial Abdominal Sepsis
Published on: December 18, 2010
Metoclopramide and cellular immune functions during polymicrobial sepsis
R Oberbeck1, D Schmitz, K Wilsenack
1Department of Trauma Surgery, University Hospital of Essen, Essen, Germany. reineroberbeck@hotmail.com
Abstract:
Metoclopramide (MCP) has been demonstrated to restore the depressed cellular immune function after hemorrhage by increasing the release of the immunomodulatory pituitary hormone prolactin. We investigated the effect of MCP on serum prolactin concentrations, on cellular immune functions (immune cell distribution, splenocyte proliferation, apoptosis and cytokine release) and on the survival 48 h after induction of a polymicrobial sepsis in mice. Administration of MCP increased circulating serum prolactin concentrations and splenocyte apoptosis rate and improved cellular cytokine release, but did not affect mortality of septic mice. We therefore conclude that administration of MCP modulated splenocyte apoptosis and cytokine release in a murine model of sepsis without an impact on the survival. Furthermore, this effect may be mediated by an increased endogenous prolactin release.
Insights
Metoclopramide (MCP) administration increased prolactin levels and modulated immune cell apoptosis and cytokine release in septic mice. However, MCP did not impact overall survival in this sepsis model.
Area of Science:
- Immunology
- Endocrinology
- Pharmacology
Background:
- Hemorrhage can impair cellular immune function.
- Metoclopramide (MCP) has shown potential in restoring immune function post-hemorrhage by influencing prolactin release.
Purpose of the Study:
- To investigate the effects of Metoclopramide (MCP) on immune responses and survival in a murine model of polymicrobial sepsis.
- To assess MCP's impact on serum prolactin, cellular immunity, and mortality.
Main Methods:
- Mice were induced with polymicrobial sepsis.
- MCP was administered to assess its effects on serum prolactin, immune cell distribution, splenocyte proliferation, apoptosis, and cytokine release.
- Survival was monitored for 48 hours post-sepsis induction.
Main Results:
- MCP administration led to increased serum prolactin concentrations.
- Splenocyte apoptosis rate increased, and cellular cytokine release was improved following MCP treatment.
- MCP administration did not significantly affect the mortality rate of septic mice.
Conclusions:
- Metoclopramide (MCP) modulates splenocyte apoptosis and cytokine release in a murine sepsis model.
- The observed immunomodulatory effects of MCP may be mediated by increased endogenous prolactin release.
- MCP did not improve survival in this specific polymicrobial sepsis model.
Related Concept Videos
Cell-mediated Immune Responses
Differentiation of Common Myeloid Progenitor Cells
Acute Inflammation II: Cellular Phase
Inflammatory Bowel Disease III: Crohn's Disease
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Colonisation of Pathogens
